Generics Industry News Search
 |
|
|
|
|
|
|
July 2014 News Archive |
|
|
| |
|
After a three-year long struggle, Medecins Sans Frontieres (MSF) has received approval from the South African Medicines Control Council (MCC) to import a dramatically more affordable version of an antibiotic, Linezolid...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca has filed a lawsuit against Mylan in the US after it filed for approval of a generic version of diabetes drug Onglyza...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Upsher-Smith Laboratories today announced the launch of Testosterone gel (1%), the generic of the newly FDA approved Vogelxo (testosterone) gel 1%, for topical use...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Impax Laboratories today announced that it has acquired from Actavis two generic products for cash consideration pursuant to a Purchase Agreement and a Supply Agreement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva today announced that the company has filed a citizen petition regarding the approvability of purported generic versions of Copaxone...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun Pharmaceutical is recalling 200 vials of the chemotherapy drug Gemcitabine in the US due to a lack of assurance of sterility...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Beximco Pharmaceuticals Limited today announces that it has received GMP from Taiwan FDA as the first Bangladeshi company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. subsidiary of French pharmaceutical company Sanofi has slapped Indian drugmaker Unimark Remedies with a lawsuit in Delaware federal court seeking to block the manufacture and sale of a generic version of Multaq...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Nippon Kayaku today announced that Nippon Kayaku has obtained the marketing approval of Infliximab BS for I.V. infusion 100mg which was developed jointly with Celltrion and Celltrion Healthcare...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sydney-based biotech NeuClone has signed a major licensing agreement and joint development partnership with The Serum Institute of India covering the manufacturing of 10 biosimilar drugs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has launched Telmisartan tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it has filed an ANDA with the FDA seeking approval to market Dalfampridine extended-release tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Generics has been granted final ANDA from the FDA for Telmisartan tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it was the first to receive final approval from the FDA for its ANDA for Ibuprofen and Phenylephrine hydrochloride tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz today announced the U.S. introduction of an authorised generic version of Diovan (Valsartan) tablets for the treatment of high blood pressure...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sanofi SA has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Delhi HC has stopped short of restraining Natco from exporting the generic version of Copaxone to the U.S...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Roche and Helsinn hit Dr. Reddy's with a complaint in New Jersey federal court on Monday, alleging that the generic-drug maker's proposed version of the anti-nausea drug Aloxi would infringe one of their patents...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
HEC Pharm received a complaint from United States District Court Southern District of Indiana about Eli Lilly and Company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Par Pharmaceutical Companies today announced that it has received final approval from the U.S. FDA for its ANDA for Fluphenazine Decanoate injection, USP 25 mg/mL...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it has filed an ANDA with the FDA seeking approval to market Doxylamine succinate and Pyridoxine hydrochloride delayed-release tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun Pharmaceutical is recalling 41,127 bottles of antidepressant Venlafaxine hydrochloride...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In the long-winding patent battle on a widely-prescribed diabetes drug, Januvia (Sitagliptin), Merck has sought a settlement to end the dispute with generic company, Glenmark...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Medac Pharma, announced that the U.S. FDA has approved Rasuvo, a subcutaneous injectable methotrexate...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Upsher-Smith today announced the launch of Topiramate extended-release capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz today announced the US market introduction of Tobramycin inhalation solution, an authorised generic version of Tobi, currently marketed by Novartis Pharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Natco is pleased to inform that the Bombay High Court upheld the compulsory license (CL) granted to the Company on Nexavar (Sorafenib tosylate)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Pharmaceuticals has received final approval from the US health regulator for its generic Fluocinonide cream used for treating a variety of skin infections...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The court fight over Pfizer's stomach drug Reglan (Metoclopramide) has yielded another ruling in Big Pharma's favor...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Depomed today announced that the U.S. District Court for the District of New Jersey entered an order preliminarily enjoining Actavis Elizabeth and Actavis from marketing a generic version of Gralise prior to the Court's issuance of an opinion in the matter...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that the U.S. District Court for the District of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to Paroxetine CR...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Three days before the start of the 20th International AIDS Conference in Melbourne, Australia, the Medicines Patent Pool (MPP) announced seven new sub-licensing agreements for the manufacture of generic HIV medicines...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett announced that it has signed an agreement with Symplmed, to be the exclusive distributor in the United States of an authorised generic version of Aceon (Perindopril erbumine tablets) in 2 mg, 4 mg and 8 mg dosage strengths...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Acorda Therapeutics, which makes the drug Ampyra to improve multiple sclerosis patients' walking, sued Mylan, accusing the company of attempting to sell a generic of the drug before its patents expire...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Homegrown drug maker Intas Pharmaceuticals has launched a generic version of blood cancer drug Azacitidine at one-fifth of the price of currently available drug for the disease...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Strides Arcolab today entered into an agreement with Bafna Pharmaceuticals to acquire majority stake of their India branded generics business...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Arena today announced that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for Belviq...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Genentech today announced that the U.S. FDA has accepted the company's supplemental Biologics License Application (sBLA) and granted Priority Review for Avastin (Bevacizumab) plus chemotherapy for the treatment of women with recurrent platinum-resistant ovarian cancer...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Gilead Sciences got to the market first with an interferon-free oral hepatitis C fighter, a category projected to hit $20 billion in sales by 2020...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Indian generics firm Lupin, some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharma firm, Strides Arcolab announced that it has received approval from the U.S. FDA for marketing of Tacrolimus capsules, used as immuno-suppressant...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan announced that the U.S. District Court for the District of New Jersey granted its motion for a temporary restraining order against Apotex and Apotex in litigation relating to Paroxetine, the authorised generic of GlaxoSmithKline's Paxil...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
U.S. rules that ensure prescription medicines are not misused have been manipulated by brand-name drug companies to fight off generic competitors, costing consumers billions of dollars...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A competitor of antibiotics maker Cubist Pharmaceuticals has agreed not to launch a generic version of its flagship drug for skin infections until at least Dec...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz announced today that the FDA has accepted its Biologics License Application for Filgrastim...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has received an AB therapeutic equivalent rating from the FDA for its previously approved NDA for Testosterone gel 1.0%...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Seven new sub-licensing agreements for the manufacture of generic HIV medicines and two new generation drugs, Atazanavir and Dolutegravir, by the MPP, is set to usher in a new era of innovative production...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Multinational drugmakers Pfizer and Forest Laboratories have filed lawsuits against Indian generic company Aurobindo, as it wants to manufacture copycat versions of drugs of which they have patents...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Since the passage of the Affordable Care Act in 2010, a streamlined regulatory path has been available in the U.S. for biosimilars: generic versions of biologic drugs, such as proteins and RNA complexes, manufactured through living systems like bacteria or viruses...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hikma Pharmaceuticals announced in a press release that it has acquired the Ben Venue Laboratories manufacturing facility in Bedford, OH...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Indian generics or copycat drug makers and multinational pharma companies are increasingly resorting to mediation to resolve patent fights...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IDT Australia is pleased to announce that it has entered into a binding Memorandum of Understanding (MOU) with Mayne Pharma's US Products division to distribute IDT's generic Temozolomide product in the US...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
InnoPharma today announced the first generic launch of Olanzapine for injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo announced that it has filed with the FDA an ANDA for Desoximetasone topical spray 0.25%...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
